U.S., March 20 -- ClinicalTrials.gov registry received information related to the study (NCT07482592) titled 'Clinical Trial of TQB3205 Capsule in Subjects With Advanced Malignant Tumors' on March 16.
Brief Summary: The trial was divided into two phases: dose escalation and dose expansion. The dosing regimens were single-dose study and continuous dosing study. A single-center, open, non-randomized, single-arm clinical trial design was adopted. Subjects with advanced malignant tumors were selected to take TQB3205 capsules orally to evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of TQB3205 capsules.
Study Start Date: March, 2026
Study Type: INTERVENTIONAL
Condition:
Advanced Malignant Cancer
Intervention: ...